UCB SA (UCBJY)
93.74
+2.57
(+2.82%)
USD |
OTCM |
Nov 22, 16:00
UCB Price: 93.74 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 22, 2024 | 92.73 | 93.75 | 92.66 | 93.74 | 9461.00 |
| Nov 21, 2024 | 91.13 | 91.50 | 90.68 | 91.17 | 15864.00 |
| Nov 20, 2024 | 89.13 | 89.79 | 88.90 | 89.67 | 14603.00 |
| Nov 19, 2024 | 86.73 | 87.38 | 86.71 | 86.95 | 9618.00 |
| Nov 18, 2024 | 88.05 | 88.05 | 87.26 | 87.63 | 10160.00 |
| Nov 15, 2024 | 88.38 | 88.39 | 87.30 | 87.90 | 15077.00 |
| Nov 14, 2024 | 94.78 | 94.78 | 93.55 | 93.55 | 6232.00 |
| Nov 13, 2024 | 96.39 | 96.60 | 95.67 | 96.31 | 14083.00 |
| Nov 12, 2024 | 97.53 | 97.57 | 96.02 | 96.57 | 6779.00 |
| Nov 11, 2024 | 98.78 | 98.87 | 97.93 | 98.25 | 14007.00 |
| Nov 08, 2024 | 99.40 | 99.40 | 99.07 | 99.17 | 25540.00 |
| Nov 07, 2024 | 98.05 | 98.47 | 97.92 | 98.21 | 7574.00 |
| Nov 06, 2024 | 98.04 | 98.11 | 97.77 | 97.77 | 2567.00 |
| Nov 05, 2024 | 97.76 | 98.65 | 97.70 | 98.59 | 9832.00 |
| Nov 04, 2024 | 97.70 | 98.02 | 96.79 | 97.31 | 129975.0 |
| Nov 01, 2024 | 97.63 | 98.33 | 97.56 | 98.04 | 108542.0 |
| Oct 31, 2024 | 95.63 | 96.16 | 95.63 | 95.97 | 6390.00 |
| Oct 30, 2024 | 96.03 | 97.44 | 96.03 | 97.10 | 4541.00 |
| Oct 29, 2024 | 97.27 | 97.74 | 96.85 | 96.97 | 3452.00 |
| Oct 28, 2024 | 96.47 | 96.47 | 96.12 | 96.12 | 7159.00 |
| Oct 25, 2024 | 97.60 | 97.60 | 96.28 | 96.28 | 3160.00 |
| Oct 24, 2024 | 95.16 | 95.66 | 95.13 | 95.55 | 19695.00 |
| Oct 23, 2024 | 93.16 | 94.05 | 93.16 | 93.64 | 91221.00 |
| Oct 22, 2024 | 92.53 | 93.11 | 92.29 | 92.72 | 111296.0 |
| Oct 21, 2024 | 94.54 | 94.60 | 94.02 | 94.24 | 4160.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
32.45
Minimum
Mar 18 2020
99.17
Maximum
Nov 08 2024
52.46
Average
49.29
Median
Price Benchmarks
| Galapagos NV | 27.13 |
| Mithra Pharmaceuticals SA | 6.75 |
| Nyxoah SA | 8.00 |
| Celyad Oncology SA | 0.245 |
| MDxHealth SA | 1.88 |
Price Related Metrics
| PE Ratio | 142.72 |
| PS Ratio | 6.235 |
| Price to Book Value | 3.706 |
| Price to Free Cash Flow | 59.76 |
| Earnings Yield | 0.70% |
| Market Cap | 35.57B |
| Operating PE Ratio | 71.44 |
| Normalized PE Ratio | 143.60 |